nodes	percent_of_prediction	percent_of_DWPC	metapath
Miglustat—GBA2—trigeminal ganglion—peripheral nervous system neoplasm	0.0055	0.264	CbGeAlD
Miglustat—UGCG—trigeminal ganglion—peripheral nervous system neoplasm	0.00542	0.261	CbGeAlD
Miglustat—UGCG—parotid gland—peripheral nervous system neoplasm	0.00512	0.246	CbGeAlD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—PTPN11—peripheral nervous system neoplasm	0.0036	0.14	CbGpPWpGaD
Miglustat—GBA2—cerebellum—peripheral nervous system neoplasm	0.0024	0.115	CbGeAlD
Miglustat—UGCG—cerebellum—peripheral nervous system neoplasm	0.00237	0.114	CbGeAlD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00224	0.0871	CbGpPWpGaD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00205	0.0797	CbGpPWpGaD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—MYC—peripheral nervous system neoplasm	0.00202	0.0784	CbGpPWpGaD
Miglustat—Back pain—Vincristine—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Pain—Topotecan—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Constipation—Topotecan—peripheral nervous system neoplasm	0.00168	0.00176	CcSEcCtD
Miglustat—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.00167	0.00176	CcSEcCtD
Miglustat—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00167	0.00175	CcSEcCtD
Miglustat—Pain—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00174	CcSEcCtD
Miglustat—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00166	0.00174	CcSEcCtD
Miglustat—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00174	CcSEcCtD
Miglustat—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00166	0.00174	CcSEcCtD
Miglustat—Cramps of lower extremities—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00174	CcSEcCtD
Miglustat—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00166	0.00174	CcSEcCtD
Miglustat—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00165	0.00173	CcSEcCtD
Miglustat—Eye disorder—Cisplatin—peripheral nervous system neoplasm	0.00165	0.00173	CcSEcCtD
Miglustat—Pain—Melphalan—peripheral nervous system neoplasm	0.00164	0.00172	CcSEcCtD
Miglustat—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00172	CcSEcCtD
Miglustat—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00163	0.00171	CcSEcCtD
Miglustat—Influenza like illness—Doxorubicin—peripheral nervous system neoplasm	0.00162	0.0017	CcSEcCtD
Miglustat—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00161	0.00169	CcSEcCtD
Miglustat—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.00161	0.00169	CcSEcCtD
Miglustat—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.0016	0.00168	CcSEcCtD
Miglustat—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.0016	0.00168	CcSEcCtD
Miglustat—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.0016	0.00168	CcSEcCtD
Miglustat—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00159	0.00167	CcSEcCtD
Miglustat—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00159	0.00167	CcSEcCtD
Miglustat—Neuropathy—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00165	CcSEcCtD
Miglustat—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00156	0.00164	CcSEcCtD
Miglustat—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00156	0.00164	CcSEcCtD
Miglustat—Thrombocytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00156	0.00163	CcSEcCtD
Miglustat—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00155	0.00162	CcSEcCtD
Miglustat—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.00154	0.00161	CcSEcCtD
Miglustat—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00154	0.00161	CcSEcCtD
Miglustat—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00154	0.00161	CcSEcCtD
Miglustat—Cramps of lower extremities—Doxorubicin—peripheral nervous system neoplasm	0.00154	0.00161	CcSEcCtD
Miglustat—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00159	CcSEcCtD
Miglustat—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00159	CcSEcCtD
Miglustat—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Miglustat—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.00151	0.00159	CcSEcCtD
Miglustat—Convulsion—Vincristine—peripheral nervous system neoplasm	0.00151	0.00158	CcSEcCtD
Miglustat—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.0015	0.00158	CcSEcCtD
Miglustat—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.00148	0.00155	CcSEcCtD
Miglustat—GBA2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00148	0.0574	CbGpPWpGaD
Miglustat—Chills—Etoposide—peripheral nervous system neoplasm	0.00145	0.00152	CcSEcCtD
Miglustat—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00152	CcSEcCtD
Miglustat—Thrombocytopenia—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00151	CcSEcCtD
Miglustat—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00151	CcSEcCtD
Miglustat—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.00143	0.0015	CcSEcCtD
Miglustat—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00141	0.00147	CcSEcCtD
Miglustat—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.0014	0.00147	CcSEcCtD
Miglustat—UGCG—IL2 signaling events mediated by PI3K—AKT1—peripheral nervous system neoplasm	0.0014	0.0544	CbGpPWpGaD
Miglustat—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00139	0.00146	CcSEcCtD
Miglustat—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00139	0.00146	CcSEcCtD
Miglustat—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.00139	0.00146	CcSEcCtD
Miglustat—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.00139	0.00146	CcSEcCtD
Miglustat—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00139	0.00145	CcSEcCtD
Miglustat—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.00145	CcSEcCtD
Miglustat—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00138	0.00144	CcSEcCtD
Miglustat—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00137	0.00144	CcSEcCtD
Miglustat—Back pain—Etoposide—peripheral nervous system neoplasm	0.00136	0.00143	CcSEcCtD
Miglustat—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00136	0.00142	CcSEcCtD
Miglustat—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Miglustat—Anorexia—Vincristine—peripheral nervous system neoplasm	0.00135	0.00142	CcSEcCtD
Miglustat—UGCG—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00135	0.0525	CbGpPWpGaD
Miglustat—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00134	0.00141	CcSEcCtD
Miglustat—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Miglustat—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.0014	CcSEcCtD
Miglustat—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00133	0.00139	CcSEcCtD
Miglustat—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00133	0.00139	CcSEcCtD
Miglustat—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00132	0.00139	CcSEcCtD
Miglustat—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Miglustat—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.00131	0.00138	CcSEcCtD
Miglustat—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00131	0.00137	CcSEcCtD
Miglustat—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.00131	0.00137	CcSEcCtD
Miglustat—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.0013	0.00136	CcSEcCtD
Miglustat—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.0013	0.00136	CcSEcCtD
Miglustat—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0013	0.00136	CcSEcCtD
Miglustat—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.00129	0.00136	CcSEcCtD
Miglustat—Migraine—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00135	CcSEcCtD
Miglustat—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00129	0.00135	CcSEcCtD
Miglustat—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00129	0.00135	CcSEcCtD
Miglustat—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00128	0.00135	CcSEcCtD
Miglustat—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00134	CcSEcCtD
Miglustat—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00127	0.00134	CcSEcCtD
Miglustat—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00133	CcSEcCtD
Miglustat—Malaise—Etoposide—peripheral nervous system neoplasm	0.00127	0.00133	CcSEcCtD
Miglustat—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00127	0.00133	CcSEcCtD
Miglustat—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00127	0.00133	CcSEcCtD
Miglustat—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00132	CcSEcCtD
Miglustat—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00126	0.00132	CcSEcCtD
Miglustat—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00126	0.00132	CcSEcCtD
Miglustat—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00125	0.00131	CcSEcCtD
Miglustat—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00124	0.0013	CcSEcCtD
Miglustat—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00124	0.0013	CcSEcCtD
Miglustat—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00123	0.00129	CcSEcCtD
Miglustat—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.00123	0.00129	CcSEcCtD
Miglustat—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00129	CcSEcCtD
Miglustat—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.00123	0.00129	CcSEcCtD
Miglustat—Headache—Topotecan—peripheral nervous system neoplasm	0.00123	0.00129	CcSEcCtD
Miglustat—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00123	0.00129	CcSEcCtD
Miglustat—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Miglustat—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Miglustat—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Miglustat—Headache—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Miglustat—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00128	CcSEcCtD
Miglustat—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Miglustat—Constipation—Vincristine—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Miglustat—Pain—Vincristine—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Miglustat—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.00121	0.00127	CcSEcCtD
Miglustat—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.0012	0.00126	CcSEcCtD
Miglustat—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00126	CcSEcCtD
Miglustat—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.0012	0.00125	CcSEcCtD
Miglustat—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00125	CcSEcCtD
Miglustat—Discomfort—Etoposide—peripheral nervous system neoplasm	0.00119	0.00124	CcSEcCtD
Miglustat—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Miglustat—Nausea—Topotecan—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Miglustat—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00116	0.00122	CcSEcCtD
Miglustat—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00116	0.00121	CcSEcCtD
Miglustat—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00121	CcSEcCtD
Miglustat—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00121	CcSEcCtD
Miglustat—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Miglustat—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Miglustat—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Miglustat—Nausea—Melphalan—peripheral nervous system neoplasm	0.00114	0.0012	CcSEcCtD
Miglustat—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.00113	0.00118	CcSEcCtD
Miglustat—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00113	0.00118	CcSEcCtD
Miglustat—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00112	0.00118	CcSEcCtD
Miglustat—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00116	CcSEcCtD
Miglustat—Anorexia—Etoposide—peripheral nervous system neoplasm	0.0011	0.00115	CcSEcCtD
Miglustat—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00114	CcSEcCtD
Miglustat—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00114	CcSEcCtD
Miglustat—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.00108	0.00114	CcSEcCtD
Miglustat—Pain—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00113	CcSEcCtD
Miglustat—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00112	CcSEcCtD
Miglustat—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00106	0.00111	CcSEcCtD
Miglustat—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00111	CcSEcCtD
Miglustat—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Miglustat—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Miglustat—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.00103	0.00108	CcSEcCtD
Miglustat—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00102	0.00107	CcSEcCtD
Miglustat—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Miglustat—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00106	CcSEcCtD
Miglustat—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.001	0.00105	CcSEcCtD
Miglustat—GBA2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000997	0.0388	CbGpPWpGaD
Miglustat—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000993	0.00104	CcSEcCtD
Miglustat—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000991	0.00104	CcSEcCtD
Miglustat—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000991	0.00104	CcSEcCtD
Miglustat—Pain—Etoposide—peripheral nervous system neoplasm	0.000983	0.00103	CcSEcCtD
Miglustat—Constipation—Etoposide—peripheral nervous system neoplasm	0.000983	0.00103	CcSEcCtD
Miglustat—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000974	0.00102	CcSEcCtD
Miglustat—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000971	0.00102	CcSEcCtD
Miglustat—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000949	0.000995	CcSEcCtD
Miglustat—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000948	0.000994	CcSEcCtD
Miglustat—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000944	0.00099	CcSEcCtD
Miglustat—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00094	0.000986	CcSEcCtD
Miglustat—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000939	0.000984	CcSEcCtD
Miglustat—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000937	0.000982	CcSEcCtD
Miglustat—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000923	0.000968	CcSEcCtD
Miglustat—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000917	0.000961	CcSEcCtD
Miglustat—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000912	0.000956	CcSEcCtD
Miglustat—UGCG—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000912	0.0355	CbGpPWpGaD
Miglustat—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000909	0.000953	CcSEcCtD
Miglustat—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000907	0.000951	CcSEcCtD
Miglustat—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000903	0.000947	CcSEcCtD
Miglustat—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000903	0.000947	CcSEcCtD
Miglustat—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000901	0.000944	CcSEcCtD
Miglustat—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000892	0.000935	CcSEcCtD
Miglustat—Headache—Vincristine—peripheral nervous system neoplasm	0.000889	0.000933	CcSEcCtD
Miglustat—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000875	0.000918	CcSEcCtD
Miglustat—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000874	0.000917	CcSEcCtD
Miglustat—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000859	0.000901	CcSEcCtD
Miglustat—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000848	0.000889	CcSEcCtD
Miglustat—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000844	0.000885	CcSEcCtD
Miglustat—Nausea—Vincristine—peripheral nervous system neoplasm	0.000843	0.000884	CcSEcCtD
Miglustat—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000839	0.00088	CcSEcCtD
Miglustat—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000835	0.000876	CcSEcCtD
Miglustat—GBA2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000829	0.0322	CbGpPWpGaD
Miglustat—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000825	0.000865	CcSEcCtD
Miglustat—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000825	0.000865	CcSEcCtD
Miglustat—Chills—Epirubicin—peripheral nervous system neoplasm	0.000814	0.000854	CcSEcCtD
Miglustat—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000809	0.000848	CcSEcCtD
Miglustat—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000798	0.000837	CcSEcCtD
Miglustat—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000795	0.000834	CcSEcCtD
Miglustat—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00079	0.000828	CcSEcCtD
Miglustat—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000787	0.000825	CcSEcCtD
Miglustat—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000784	0.000823	CcSEcCtD
Miglustat—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000778	0.000816	CcSEcCtD
Miglustat—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000767	0.000804	CcSEcCtD
Miglustat—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000764	0.000801	CcSEcCtD
Miglustat—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00076	0.000797	CcSEcCtD
Miglustat—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000759	0.000796	CcSEcCtD
Miglustat—UGCG—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000758	0.0295	CbGpPWpGaD
Miglustat—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.00079	CcSEcCtD
Miglustat—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000746	0.000782	CcSEcCtD
Miglustat—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000735	0.000771	CcSEcCtD
Miglustat—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000733	0.000769	CcSEcCtD
Miglustat—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000731	0.000767	CcSEcCtD
Miglustat—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000731	0.000766	CcSEcCtD
Miglustat—GBA2—Metabolism—GNS—peripheral nervous system neoplasm	0.000721	0.028	CbGpPWpGaD
Miglustat—Headache—Etoposide—peripheral nervous system neoplasm	0.00072	0.000755	CcSEcCtD
Miglustat—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.00072	0.000755	CcSEcCtD
Miglustat—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000712	0.000747	CcSEcCtD
Miglustat—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.000744	CcSEcCtD
Miglustat—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00071	0.000744	CcSEcCtD
Miglustat—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000707	0.000741	CcSEcCtD
Miglustat—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000703	0.000737	CcSEcCtD
Miglustat—GBA2—Metabolism—NME1—peripheral nervous system neoplasm	0.000691	0.0269	CbGpPWpGaD
Miglustat—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000684	0.000718	CcSEcCtD
Miglustat—Nausea—Etoposide—peripheral nervous system neoplasm	0.000683	0.000716	CcSEcCtD
Miglustat—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000678	0.000711	CcSEcCtD
Miglustat—GBA2—Metabolism—COX2—peripheral nervous system neoplasm	0.000665	0.0259	CbGpPWpGaD
Miglustat—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000664	0.000697	CcSEcCtD
Miglustat—UGCG—Metabolism—GNS—peripheral nervous system neoplasm	0.000659	0.0257	CbGpPWpGaD
Miglustat—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000659	0.000691	CcSEcCtD
Miglustat—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000658	0.00069	CcSEcCtD
Miglustat—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.000689	CcSEcCtD
Miglustat—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000633	0.000664	CcSEcCtD
Miglustat—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000632	0.000663	CcSEcCtD
Miglustat—UGCG—Metabolism—NME1—peripheral nervous system neoplasm	0.000632	0.0246	CbGpPWpGaD
Miglustat—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000631	0.000662	CcSEcCtD
Miglustat—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000615	0.000645	CcSEcCtD
Miglustat—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000614	0.000644	CcSEcCtD
Miglustat—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.000638	CcSEcCtD
Miglustat—UGCG—Metabolism—COX2—peripheral nervous system neoplasm	0.000608	0.0237	CbGpPWpGaD
Miglustat—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000585	0.000613	CcSEcCtD
Miglustat—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000584	0.000612	CcSEcCtD
Miglustat—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000583	0.000611	CcSEcCtD
Miglustat—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000579	0.000607	CcSEcCtD
Miglustat—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000596	CcSEcCtD
Miglustat—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000595	CcSEcCtD
Miglustat—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00056	0.000588	CcSEcCtD
Miglustat—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000584	CcSEcCtD
Miglustat—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000556	0.000583	CcSEcCtD
Miglustat—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000578	CcSEcCtD
Miglustat—Pain—Epirubicin—peripheral nervous system neoplasm	0.000551	0.000578	CcSEcCtD
Miglustat—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000539	0.000566	CcSEcCtD
Miglustat—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000536	0.000562	CcSEcCtD
Miglustat—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000557	CcSEcCtD
Miglustat—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000527	0.000553	CcSEcCtD
Miglustat—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000551	CcSEcCtD
Miglustat—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000544	CcSEcCtD
Miglustat—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.00054	CcSEcCtD
Miglustat—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000514	0.000539	CcSEcCtD
Miglustat—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.000535	CcSEcCtD
Miglustat—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.000535	CcSEcCtD
Miglustat—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00051	0.000534	CcSEcCtD
Miglustat—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000515	CcSEcCtD
Miglustat—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000488	0.000511	CcSEcCtD
Miglustat—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000471	0.000494	CcSEcCtD
Miglustat—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000485	CcSEcCtD
Miglustat—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000441	0.000463	CcSEcCtD
Miglustat—GBA2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000437	0.017	CbGpPWpGaD
Miglustat—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000449	CcSEcCtD
Miglustat—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000447	CcSEcCtD
Miglustat—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00043	CcSEcCtD
Miglustat—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000408	0.000428	CcSEcCtD
Miglustat—Headache—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000423	CcSEcCtD
Miglustat—UGCG—Metabolism—ENO2—peripheral nervous system neoplasm	0.000399	0.0155	CbGpPWpGaD
Miglustat—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.000414	CcSEcCtD
Miglustat—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000383	0.000402	CcSEcCtD
Miglustat—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000398	CcSEcCtD
Miglustat—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000392	CcSEcCtD
Miglustat—GBA2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000369	0.0144	CbGpPWpGaD
Miglustat—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000372	CcSEcCtD
Miglustat—GBA2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000352	0.0137	CbGpPWpGaD
Miglustat—GBA2—Metabolism—TH—peripheral nervous system neoplasm	0.000347	0.0135	CbGpPWpGaD
Miglustat—UGCG—Metabolism—BCHE—peripheral nervous system neoplasm	0.000337	0.0131	CbGpPWpGaD
Miglustat—UGCG—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000322	0.0125	CbGpPWpGaD
Miglustat—UGCG—Metabolism—TH—peripheral nervous system neoplasm	0.000317	0.0123	CbGpPWpGaD
Miglustat—GBA2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000283	0.011	CbGpPWpGaD
Miglustat—GBA2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000278	0.0108	CbGpPWpGaD
Miglustat—UGCG—Metabolism—GNAS—peripheral nervous system neoplasm	0.000259	0.0101	CbGpPWpGaD
Miglustat—UGCG—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000254	0.00989	CbGpPWpGaD
Miglustat—GBA2—Metabolism—AKT1—peripheral nervous system neoplasm	7.64e-05	0.00297	CbGpPWpGaD
Miglustat—UGCG—Metabolism—AKT1—peripheral nervous system neoplasm	6.99e-05	0.00272	CbGpPWpGaD
